Nature's Miracle Declares Non-Reliance on Prior Financials Due to Omitted Short-Term Loans
NMHI sits 17% above its 52-week low of $0.001.
Summary
Nature's Miracle Holding Inc. has announced that its Q3 2025 financial statements can no longer be relied upon due to an erroneously omitted amount in short-term loans, necessitating a restatement.
Key Events · Legal and Risk Events · NMHI
-
Non-Reliance Declared
Management determined that previously issued unaudited condensed consolidated financial statements and related disclosures for the period ended September 30, 2025, included in the Form 10-Q filed on November 14, 2025, can no longer be relied upon.
-
Reason for Non-Reliance
The determination was made to correctly record an amount in short-term loans that was erroneously omitted from the original filing.
-
Financial Restatement Planned
The company will file an amendment to the original filing via a Form 10-Q/A for the quarterly period ended September 30, 2025, to appropriately include the recording of the short-term loan.
-
Auditor Discussion
Management and the Audit Committee have discussed these matters with the company's independent registered public accounting firm, WWC, P.C.
Analysis · NMHI · Technology
Nature's Miracle Holding Inc. has declared that its previously issued unaudited condensed consolidated financial statements for the period ended September 30, 2025, can no longer be relied upon. This is a critical event as it signals a material error in the company's financial reporting, specifically the erroneous omission of short-term loans. Such a declaration significantly erodes investor confidence in the accuracy of the company's financial health and can lead to a re-evaluation of its valuation. The company plans to file an amended 10-Q/A to correct these statements, but the initial disclosure of non-reliance is a strong negative signal.
At the time of this filing, NMHI was trading at $0.00 on OTC in the Technology sector, with a market capitalization of approximately $33.2K. The 52-week trading range was $0.00 to $0.46. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.